HistoSonics

HistoSonics is a developer of non-invasive robotic platforms and sonic therapy devices, founded in 2009, with its headquarters located in Minnesota, USA. The company has offices in Ann Arbor, Michigan, and Minneapolis, Minnesota.Currently, HistoSonics has developed a new non-invasive platform called Edison, which uses advanced imaging technology and proprietary sensing technology to provide non-invasive, personalized treatment methods. It can deliver pulses inside the patient’s body to inform the treating physician of the energy required to generate bubble clouds and destroy cells, thereby providing personalized treatment for each patient. Moreover, there will be no incisions or sutures left on the patient's body, reducing concerns about scar removal for some patients. HistoSonics’ non-invasive platform Edison combines advanced robotics and imaging technology with proprietary sensing technology to provide personalized treatment. It utilizes histotripsy and focused acoustic energy to generate pressure sufficient to liquefy and destroy target tissues at the subcellular level, aiming to deliver precise and controllable personalized, tissue-specific treatment. This novel procedure, known as Robotic Assisted Sonic Therapy (RAST SM), leverages HistoSonics' proprietary technology to offer potentially significant advantages, including the unique ability of physicians to monitor tissue destruction under continuous real-time visualization and unparalleled control.